Abstract
Invasive aspergillosis infection due to Aspergillus fumigatus specie causes extensive morbidity and mortality, especially among immunosuppressed patients. Caspofungin is a second choice drug to treat aspergilosis, since azole resistant strains have emerged. It belongs to the first class of cell wall-active agents and target the fungal-specific enzyme glucan synthase, which catalyzes the b…